Mutual Funds are considered as one of the best option for investment. Considering its benefits of returns and tax saving option has made it the most favourable. However, it does involves risk.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Equity mutual funds are witnessing strong outflows lately, despite Indian markets touching all-time highs. As per the data by Association of Mutual Funds in India, the outflows in equity mutual funds have been rising from past four months. 

In December last year, the outflows were Rs 7,932 crore, which jumped to Rs 12,355 crore in the month of January, 2017. In February the outflows were Rs 13,963 crore and in March, it was Rs 20,658 crore, which is nearly three times than that was in December, 2016.

equity-pharma, there are funds which gave nearly 3% of negative return in just one week. The week's average return for Pharma was -1.89% and for international funds were -0.21%.

If you look at the table above, Tata India Pharma DP (G) with net asset value (NAV) of 9.19 gave negative return of 2.63% and close to it was Tata IndiaPharma (G) with 8.98 NAV dropped 2.62%. Third was SBI Pharma DP (G) with NAV of 135.02, declined by 1.96% and in line with is was SBI Pharma (G) with 128.99 NAV dropping 1.98% in one week.

Moving ahead, Reliance Pharma (G) with 128.97 NAV plunged 1.57% and Reliance Pharma DP (G) with 133.50 NAV dropped by 1.56% during the week. Moreover, UTI GSF-Pharma&HC (G) with 85.66 NAV declining by 1.43% in a week and UTI GSF-Pharma&HCDP (G) with 88.86 NAV dropped by 1.41%.

International Funds too declined by 3% in one week. BirlaSL CEF - GAP (G) with NAV of 20.72% plunged 2.93% and BirlaSL CEF - GAP DP (G) with NAV of 21.11 dropped by 2.92% in one week.

So, to get better returns in mutual funds, look at the long-term investment!